These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 12954624

  • 1. A vascular endothelial growth factor high affinity receptor 1-specific peptide with antiangiogenic activity identified using a phage display peptide library.
    El-Mousawi M, Tchistiakova L, Yurchenko L, Pietrzynski G, Moreno M, Stanimirovic D, Ahmad D, Alakhov V.
    J Biol Chem; 2003 Nov 21; 278(47):46681-91. PubMed ID: 12954624
    [Abstract] [Full Text] [Related]

  • 2. Selection of high affinity human neutralizing antibodies to VEGFR2 from a large antibody phage display library for antiangiogenesis therapy.
    Lu D, Jimenez X, Zhang H, Bohlen P, Witte L, Zhu Z.
    Int J Cancer; 2002 Jan 20; 97(3):393-9. PubMed ID: 11774295
    [Abstract] [Full Text] [Related]

  • 3. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
    Bae DG, Kim TD, Li G, Yoon WH, Chae CB.
    Clin Cancer Res; 2005 Apr 01; 11(7):2651-61. PubMed ID: 15814646
    [Abstract] [Full Text] [Related]

  • 4. Tailoring in vitro selection for a picomolar affinity human antibody directed against vascular endothelial growth factor receptor 2 for enhanced neutralizing activity.
    Lu D, Shen J, Vil MD, Zhang H, Jimenez X, Bohlen P, Witte L, Zhu Z.
    J Biol Chem; 2003 Oct 31; 278(44):43496-507. PubMed ID: 12917408
    [Abstract] [Full Text] [Related]

  • 5. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
    Starzec A, Vassy R, Martin A, Lecouvey M, Di Benedetto M, Crépin M, Perret GY.
    Life Sci; 2006 Nov 17; 79(25):2370-81. PubMed ID: 16959272
    [Abstract] [Full Text] [Related]

  • 6. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B, Singh J, Gingrich D, Angeles T, Albom M, Yang S, Chang H, Robinson C, Hunter K, Dobrzanski P, Jones-Bolin S, Pritchard S, Aimone L, Klein-Szanto A, Herbert JM, Bono F, Schaeffer P, Casellas P, Bourie B, Pili R, Isaacs J, Ator M, Hudkins R, Vaught J, Mallamo J, Dionne C.
    Cancer Res; 2003 Sep 15; 63(18):5978-91. PubMed ID: 14522925
    [Abstract] [Full Text] [Related]

  • 7. A novel peptide isolated from a phage display library inhibits tumor growth and metastasis by blocking the binding of vascular endothelial growth factor to its kinase domain receptor.
    Hetian L, Ping A, Shumei S, Xiaoying L, Luowen H, Jian W, Lin M, Meisheng L, Junshan Y, Chengchao S.
    J Biol Chem; 2002 Nov 08; 277(45):43137-42. PubMed ID: 12183450
    [Abstract] [Full Text] [Related]

  • 8. Antiangiogenic effect by SU5416 is partly attributable to inhibition of Flt-1 receptor signaling.
    Itokawa T, Nokihara H, Nishioka Y, Sone S, Iwamoto Y, Yamada Y, Cherrington J, McMahon G, Shibuya M, Kuwano M, Ono M.
    Mol Cancer Ther; 2002 Mar 08; 1(5):295-302. PubMed ID: 12489845
    [Abstract] [Full Text] [Related]

  • 9. Peptides derived from human decorin leucine-rich repeat 5 inhibit angiogenesis.
    Sulochana KN, Fan H, Jois S, Subramanian V, Sun F, Kini RM, Ge R.
    J Biol Chem; 2005 Jul 29; 280(30):27935-48. PubMed ID: 15923192
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
    Haspel HC, Scicli GM, McMahon G, Scicli AG.
    Microvasc Res; 2002 May 29; 63(3):304-15. PubMed ID: 11969307
    [Abstract] [Full Text] [Related]

  • 11. Src kinase becomes preferentially associated with the VEGFR, KDR/Flk-1, following VEGF stimulation of vascular endothelial cells.
    Chou MT, Wang J, Fujita DJ.
    BMC Biochem; 2002 Dec 31; 3():32. PubMed ID: 12509223
    [Abstract] [Full Text] [Related]

  • 12. Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF.
    Jia H, Jezequel S, Löhr M, Shaikh S, Davis D, Soker S, Selwood D, Zachary I.
    Biochem Biophys Res Commun; 2001 Apr 27; 283(1):164-73. PubMed ID: 11322784
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of human leukemia in an animal model with human antibodies directed against vascular endothelial growth factor receptor 2. Correlation between antibody affinity and biological activity.
    Zhu Z, Hattori K, Zhang H, Jimenez X, Ludwig DL, Dias S, Kussie P, Koo H, Kim HJ, Lu D, Liu M, Tejada R, Friedrich M, Bohlen P, Witte L, Rafii S.
    Leukemia; 2003 Mar 27; 17(3):604-11. PubMed ID: 12646950
    [Abstract] [Full Text] [Related]

  • 14. Role of VEGF receptor-1 (Flt-1) in mediating calcium-dependent nitric oxide release and limiting DNA synthesis in human trophoblast cells.
    Ahmed A, Dunk C, Kniss D, Wilkes M.
    Lab Invest; 1997 Jun 27; 76(6):779-91. PubMed ID: 9194854
    [Abstract] [Full Text] [Related]

  • 15. Green tea extract inhibits angiogenesis of human umbilical vein endothelial cells through reduction of expression of VEGF receptors.
    Kojima-Yuasa A, Hua JJ, Kennedy DO, Matsui-Yuasa I.
    Life Sci; 2003 Jul 25; 73(10):1299-313. PubMed ID: 12850245
    [Abstract] [Full Text] [Related]

  • 16. Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis.
    Binétruy-Tournaire R, Demangel C, Malavaud B, Vassy R, Rouyre S, Kraemer M, Plouët J, Derbin C, Perret G, Mazié JC.
    EMBO J; 2000 Apr 03; 19(7):1525-33. PubMed ID: 10747021
    [Abstract] [Full Text] [Related]

  • 17. Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt 1.
    Landgren E, Schiller P, Cao Y, Claesson-Welsh L.
    Oncogene; 1998 Jan 22; 16(3):359-67. PubMed ID: 9467961
    [Abstract] [Full Text] [Related]

  • 18. Novel short peptides isolated from phage display library inhibit vascular endothelial growth factor activity.
    Erdag B, Balcioglu KB, Kumbasar A, Celikbicak O, Zeder-Lutz G, Altschuh D, Salih B, Baysal K.
    Mol Biotechnol; 2007 Jan 22; 35(1):51-63. PubMed ID: 17401149
    [Abstract] [Full Text] [Related]

  • 19. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
    Lu D, Jimenez X, Zhang H, Wu Y, Bohlen P, Witte L, Zhu Z.
    Cancer Res; 2001 Oct 01; 61(19):7002-8. PubMed ID: 11585724
    [Abstract] [Full Text] [Related]

  • 20. Polyproline-type helical-structured low-molecular weight heparin (LMWH)-taurocholate conjugate as a new angiogenesis inhibitor.
    Lee E, Kim YS, Bae SM, Kim SK, Jin S, Chung SW, Lee M, Moon HT, Jeon OC, Park RW, Kim IS, Byun Y, Kim SY.
    Int J Cancer; 2009 Jun 15; 124(12):2755-65. PubMed ID: 19243020
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.